Amgen's experimental jab causes 20 per cent weight loss in early results
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
biopharma-reporter23h
Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug
MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.
Amgen Obesity Drug More Effective Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?
Shares of Amgen (NASDAQ: AMGN) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large ...
What if every germ hit you at the exact same time? An immunologist explains
Your immune system is often able to fend off pathogens it’s never seen before. But defending your body against all of them ...
Indiatimes12h
WORLD NEWS
Kamala Harris released a Thanksgiving video in which she and her husband, Doug Emhoff, shared their gratitude for family, friends, and service members. Social media users noted she wore the same ...